Sanara MedTech Inc. develops, markets and distributes skin and wound care products to physicians, hospitals, clinics, and post-acute care settings in the United States. The company is headquartered in Fort Worth, Texas.
| Revenue (TTM) | $107.48M |
| Gross Profit (TTM) | $99.87M |
| EBITDA | $13.52M |
| Operating Margin | 9.52% |
| Return on Equity | 2.86% |
| Return on Assets | 8.27% |
| Revenue/Share (TTM) | $12.41 |
| Book Value | $0.66 |
| Price-to-Book | 30.17 |
| Price-to-Sales (TTM) | 1.98 |
| EV/Revenue | 2.296 |
| EV/EBITDA | 21.89 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 18.60% |
| Shares Outstanding | $9.16M |
| Float | $4.74M |
| % Insiders | 53.28% |
| % Institutions | 16.64% |
Volatility is currently expanding